US49720K2006 - Common Stock
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
/PRNewswire/ -- TuHURA Biosciences, Inc. ("TuHURA"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome resistance...
KVA12123 is a rationally targeted, anti-VISTA antibody checkpoint inhibitor to reverse VISTA immune suppression and remodel the tumor microenvironment (TME) to...
/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara"), a biopharmaceutical company focused on the development of new solid tumor cancer...
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
/PRNewswire/ -- TuHURA Biosciences, Inc. ("TuHURA"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome resistance...
It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning!
Pre-market stock movers are a great way to start the trading week and we have all of the hottest news worth reading about on Monday!
Kintara Therapeutics just reported results for the third quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Kintara Therapeutics (NASDAQ:KTRA) just reported results for the third quarter ...
/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law...